{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T21:57:22Z","timestamp":1781647042649,"version":"3.54.5"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T00:00:00Z","timestamp":1775260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:00:00Z","timestamp":1779062400000},"content-version":"vor","delay-in-days":44,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Antibiotics remain vital for managing bacterial infections; however, their misuse contributes significantly to the rise of antimicrobial resistance (AMR). To guide stewardship and slow resistance, the World Health Organization (WHO) urges regular monitoring of hospital antibiotic use using the Access, Watch, Reserve (AWaRe) analysis, defined daily dose (DDD) metrics, and the drug utilisation 90% (DU90%) index. However, evidence on the patterns of inpatient antibiotic use and consumption in Ethiopia remains limited. This study, therefore, assessed prescribing patterns and consumption at Ayder Comprehensive Specialized Hospital, Northern Ethiopia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A prospective cross-sectional study was conducted among inpatients receiving antibiotics in medical, surgical, paediatric, and gynaecology\/obstetrics (Gyn\/Obs) wards between June and September 2024. Prescriptions were evaluated using the WHO-AWaRe classification, whereas consumption was measured in DDD\/100 bed-days and the DU90% index. The data were analysed descriptively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 865 inpatients, 1,491 antibiotic prescriptions were recorded. Ceftriaxone (41%), metronidazole (21.9%), and vancomycin (9.4%) were the most commonly prescribed antibiotics. Watch antibiotics accounted for 64.1% of prescriptions and Access covered 35.9%, deviating from the recommendation that \u2265\u200970% should be from Access. The total antibiotic consumption was 180.1 DDD\/100 bed-days, with ceftriaxone (73.2), metronidazole (45.7), and vancomycin (19.5) being the most frequently consumed antibiotics. The DU90% segment included five antibiotics (ceftriaxone, metronidazole, vancomycin, ceftazidime, and azithromycin), which together accounted for 91.4% of the total consumption.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Antibiotic prescription at this comprehensive specialized tertiary hospital was dominated by Watch antibiotics, particularly ceftriaxone, with overall consumption rates higher than those reported in many regional and global studies. These findings suggest suboptimal antibiotic use in a referral-level setting and emphasize the need for strengthened antimicrobial stewardship programme.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical trial number<\/jats:title>\n                    <jats:p>Not applicable.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-026-13254-1","type":"journal-article","created":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T09:24:01Z","timestamp":1775294641000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Antibiotic prescribing patterns and consumption at a comprehensive specialized hospital in northern Ethiopia: a prospective cross-sectional study underscoring the need for antimicrobial stewardship"],"prefix":"10.1186","volume":"26","author":[{"given":"Haftom Yirga","family":"Tsegay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berhane Yohannes","family":"Hailu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gebrehiwot Gebremedhin","family":"Tafere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filmon Beyenne","family":"Demoz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadelech Yilma","family":"Sisay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muuz Gebru","family":"Sahle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kald Beshir","family":"Tuem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,4]]},"reference":[{"key":"13254_CR1","doi-asserted-by":"publisher","unstructured":"Siaba S, Casal B, L\u00f3pez-Mart\u00ednez I. The economics of antibiotic resistance: a systematic review and meta-analysis based on global research. Appl Health Econ Health Policy [Internet]. 2025 Aug 30 [cited 2025 Sept 20]; Available from: https:\/\/doi.org\/10.1007\/s40258-025-01001-7.","DOI":"10.1007\/s40258-025-01001-7"},{"issue":"10325","key":"13254_CR2","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","volume":"399","author":"CJ Murray","year":"2022","unstructured":"Murray CJ, Ikuta KS, Sharara F, Swetschinski L, Robles Aguilar G, Gray A, et al. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022;399(10325):629\u201355.","journal-title":"Lancet"},{"key":"13254_CR3","unstructured":"Naghavi M, Vollset SE, Ikuta KS, Swetschinski LR, Gray AP, Wool EE, et al. Global burden of bacterial antimicrobial resistance 1990\u20132021: a systematic analysis with forecasts to 2050. Lancet. 2024 Sept 28;404(10459):1199\u2013226."},{"issue":"10","key":"13254_CR4","first-page":"1362","volume":"11","author":"M Irfan","year":"2022","unstructured":"Irfan M, Almotiri A, AlZeyadi ZA. Antimicrob Resist Its Drivers\u2014A Rev Antibiot. 2022;11(10):1362.","journal-title":"Antimicrob Resist Its Drivers\u2014A Rev Antibiot"},{"issue":"1","key":"13254_CR5","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1186\/s12889-025-21553-6","volume":"25","author":"PM Ndaki","year":"2025","unstructured":"Ndaki PM, Mwanga JR, Mushi MF, Konje ET, Mwita SM, Mshana SE. Drivers of inappropriate use of antibiotics among community members in low- and middle-income countries: a systematic review of qualitative studies. BMC Public Health. 2025;25(1):705.","journal-title":"BMC Public Health"},{"key":"13254_CR6","unstructured":"WHO. Global action plan on antimicrobial resistance [Internet]. 2016 [cited 2024 Oct 15]. Available from: https:\/\/www.who.int\/publications\/i\/item\/9789241509763."},{"key":"13254_CR7","unstructured":"FDRE. Antimicrobial resistance prevention and containment strategic plan the one health approach. 2021\u20132025 [Internet]. Federal Democratic Republic of Ethiopia; 2021 [cited 2025 Dec 20]. Available from: https:\/\/cdn.who.int\/media\/docs\/default-source\/antimicrobial-resistance\/amr-spc-npm\/nap-library\/ethiopia-amr-strategic-plan-2021_2025.pdf?sfvrsn=8ef921ca_3&download=true."},{"key":"13254_CR8","unstructured":"WHO. The WHO AWaRe (Access, Watch, Reserve) antibiotic book [Internet]. 2022 [cited 2025 Sept 20]. Available from: https:\/\/www.who.int\/publications\/i\/item\/9789240062382."},{"key":"13254_CR9","unstructured":"United Nations. Political declaration of the high-level meeting on antimicrobial resistance, 9 September 2024. [Internet]. UNGA. 2024 [cited 2025 Dec 20]. Available from: https:\/\/www.un.org\/pga\/wp-content\/uploads\/sites\/108\/2024\/09\/FINAL-Text-AMR-to-PGA.pdf."},{"key":"13254_CR10","unstructured":"WHO. Defined Daily Dose (DDD) [Internet]. 2025 [cited 2025 Sept 20]. Available from: https:\/\/www.who.int\/tools\/atc-ddd-toolkit\/about-ddd."},{"issue":"2","key":"13254_CR11","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s002280050431","volume":"54","author":"U Bergman","year":"1998","unstructured":"Bergman U, Popa C, Tomson Y, Wettermark B, Einarson TR, Aberg H, et al. Drug utilization 90%--a simple method for assessing the quality of drug prescribing. Eur J Clin Pharmacol. 1998;54(2):113\u20138.","journal-title":"Eur J Clin Pharmacol"},{"key":"13254_CR12","doi-asserted-by":"crossref","unstructured":"Wettermark B, Pehrsson A, Jinnerot D, Bergman U. Drug utilisation 90% profiles\u2013a useful tool for quality assessment of prescribing in primary health care in Stockholm. Pharmacoepidemiol Drug Saf. 2003 Sept;12(6):499\u2013510.","DOI":"10.1002\/pds.852"},{"key":"13254_CR13","doi-asserted-by":"crossref","unstructured":"Dereje B, Workneh A, Megersa A, Yibabie S. Prescribing pattern and associated factors in community pharmacies: a cross-sectional study using AWaRe classification and WHO antibiotic prescribing indicators in Dire Dawa, Ethiopia. Drugs - Real World Outcomes. 2023 Sept;10(3):459\u201369.","DOI":"10.1007\/s40801-023-00367-1"},{"issue":"1","key":"13254_CR14","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/s13756-024-01490-6","volume":"13","author":"GG Hailesilase","year":"2024","unstructured":"Hailesilase GG, Welegebrial BG, Weres MG, Gebrewahd SA. WHO\/INRUD prescribing indicators with a focus on antibiotics utilization patterns at outpatient department of Adigrat general hospital, Tigrai, Ethiopia: a retrospective cross-sectional study. Antimicrob Resist Infect Control. 2024;13(1):133.","journal-title":"Antimicrob Resist Infect Control"},{"issue":"1","key":"13254_CR15","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s40545-022-00490-4","volume":"15","author":"M Dechasa","year":"2022","unstructured":"Dechasa M, Chelkeba L, Jorise A, Sefera B, Melaku T. Antibiotics use evaluation among hospitalized adult patients at Jimma Medical Center, southwestern Ethiopia: the way to pave for antimicrobial stewardship. J Pharm Policy Pract. 2022;15(1):84.","journal-title":"J Pharm Policy Pract"},{"issue":"3","key":"13254_CR16","doi-asserted-by":"publisher","first-page":"282","DOI":"10.4274\/tjps.galenos.2020.11456","volume":"18","author":"V Mugada","year":"2021","unstructured":"Mugada V, Mahato V, Andhavaram D, Vajhala SM. Evaluation of prescribing patterns of antibiotics using selected indicators for antimicrobial use in hospitals and the access, watch, reserve (AWaRe) classification by the World Health Organization. Turkish J Pharm Sci. 2021;18(3):282.","journal-title":"Turkish J Pharm Sci"},{"issue":"2","key":"13254_CR17","doi-asserted-by":"publisher","first-page":"156","DOI":"10.26719\/emhj.24.031","volume":"30","author":"U Sajjad","year":"2024","unstructured":"Sajjad U, Afzal N, Asif M, Rehman MB, Afridi AU, Kazmi T. Evaluation of antibiotic prescription patterns using WHO AWaRe classification. East Mediterr Health J. 2024;30(2):156\u201362.","journal-title":"East Mediterr Health J"},{"key":"13254_CR18","doi-asserted-by":"crossref","unstructured":"Nsojo A, George L, Mwasomola D, Tawete J, Mbotwa CH, Mweya CN, et al. Prescribing patterns of antimicrobials according to the WHO AWaRe classification at a tertiary referral hospital in the southern highlands of Tanzania. Infect Prev Pract. 2024 Jun;6(2):100347.","DOI":"10.1016\/j.infpip.2024.100347"},{"issue":"1","key":"13254_CR19","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1186\/s12913-018-3107-9","volume":"18","author":"G Gutema","year":"2018","unstructured":"Gutema G, H\u00e5konsen H, Engidawork E, Toverud EL. Multiple challenges of antibiotic use in a large hospital in Ethiopia \u2013 a ward-specific study showing high rates of hospital-acquired infections and ineffective prophylaxis. BMC Health Serv Res. 2018;18(1):326.","journal-title":"BMC Health Serv Res"},{"key":"13254_CR20","doi-asserted-by":"crossref","unstructured":"Hamdi S, Ibak G, Ayse S, Ali K, Serdar K, Murat S. Application of ATC\/DDD methodology to evaluate of antibiotic use in a general hospital in Turkey. Annal Clin Microbiol Antimicrobial. 2013 Sept 3;12:23.","DOI":"10.1186\/1476-0711-12-23"},{"issue":"2","key":"13254_CR21","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.jiph.2013.09.007","volume":"7","author":"F Bozkurt","year":"2014","unstructured":"Bozkurt F, Kaya S, Tekin R, Gulsun S, Deveci O, Dayan S, et al. Analysis of antimicrobial consumption and cost in a teaching hospital. J Infect Public Health. 2014;7(2):161\u20139.","journal-title":"J Infect Public Health"},{"issue":"1","key":"13254_CR22","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1186\/s12879-023-08517-0","volume":"23","author":"L Sulaiman","year":"2023","unstructured":"Sulaiman L, Cee W, Jbw SS, Sk R, Js C. Antibiotic use and consumption among medical patients of two hospitals in Sierra Leone: a descriptive report. BMC Infect Dis. 2023;23(1):737.","journal-title":"BMC Infect Dis"},{"issue":"4","key":"13254_CR23","doi-asserted-by":"publisher","first-page":"251","DOI":"10.46542\/pe.2023.234.251258","volume":"23","author":"MR Andarsari","year":"2023","unstructured":"Andarsari MR, Khosyyatillah I, Sholichah A, Shinta DW, Wibisono C, Khotib J. Application of ATC\/DDD methodology to analyse antibiotic consumption in internal medicine department: A review. Pharm Educ. 2023;23(4):251\u20138.","journal-title":"Pharm Educ"},{"issue":"1","key":"13254_CR24","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1186\/s12879-024-09686-2","volume":"24","author":"R Masalma","year":"2024","unstructured":"Masalma R, Ghanim A, Jarrar M, Zidan T, Alkaiyat A, Abdalla M, et al. Antibiotic utilization at an orthopedic inpatient department in a large governmental hospital in the north of the West Bank, Palestine; a retrospective observational study. BMC Infect Dis. 2024;24(1):851.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"13254_CR25","doi-asserted-by":"publisher","first-page":"51","DOI":"10.18203\/2319-2003.ijbcp20233891","volume":"13","author":"R Marchiella","year":"2024","unstructured":"Marchiella R, Khairunnisa K, Wiryanto W. Antibiotic utilization profile in surgical ward at secondary government hospital. Int J Basic Clin Pharmacol. 2024;13(1):51\u20136.","journal-title":"Int J Basic Clin Pharmacol"},{"key":"13254_CR26","unstructured":"Amare F, Berhe DF, Hadgu A, Hishe HZ, Akaleweld M. Drug use evaluation of ceftriaxone: the case of ayder referral hospital, Mekelle, Ethiopia. Int J Pharm Sci Res. 2012 Jul 1;3(7):2191\u20135."},{"issue":"B1","key":"13254_CR27","first-page":"1","volume":"15","author":"S Abrha","year":"2015","unstructured":"Abrha S, Assefa R, Molla F, Wondimu A, Assen A. Antibiotics Utilization and their Cost in Ayder Referral Hospital, Mekelle, Ethiopia. Global J Med Res. 2015;15(B1):1\u20137.","journal-title":"Global J Med Res"},{"issue":"2","key":"13254_CR28","doi-asserted-by":"publisher","first-page":"57","DOI":"10.31254\/jsir.2015.4202","volume":"4","author":"HB Mezgebe","year":"2015","unstructured":"Mezgebe HB, Tadesse B, Legesse B. Antibiotics prescribing pattern in pediatric unit of Ayder referral hospital, Tigray region, Northern Ethiopia. J Sci Innov Res. 2015;4(2):57\u201360.","journal-title":"J Sci Innov Res"},{"issue":"1","key":"13254_CR29","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3390\/antibiotics13010024","volume":"13","author":"Y Thakral","year":"2024","unstructured":"Thakral Y, Sahay S, Mukherjee A. Microfoundations of Data-Driven Antimicrobial Stewardship Policy (ASP). Antibiotics. 2024;13(1):24.","journal-title":"Antibiotics"},{"issue":"1","key":"13254_CR30","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s13756-024-01369-6","volume":"13","author":"MGD Harun","year":"2024","unstructured":"Harun MGD, Sumon SA, Hasan I, Akther FM, Islam MS, Anwar MdMU. Barriers, facilitators, perceptions and impact of interventions in implementing antimicrobial stewardship programs in hospitals of low-middle and middle countries: a scoping review. Antimicrob Resist Infect Control. 2024;13(1):8.","journal-title":"Antimicrob Resist Infect Control"},{"key":"13254_CR31","unstructured":"WHO. AWaRe classification of antibiotics for evaluation and monitoring of use [Internet]. 2023 [cited 2024 Oct 23]. Available from: https:\/\/www.who.int\/publications\/i\/item\/WHO-MHP-HPS-EML-2023.04."},{"key":"13254_CR32","unstructured":"WHO. ATCDDD - ATC\/DDD Index [Internet]. WHO collaborating centre for drug statistics methodology. 2025 [cited 2025 Sept 23]. Available from: https:\/\/atcddd.fhi.no\/atc_ddd_index\/."},{"issue":"2","key":"13254_CR33","doi-asserted-by":"publisher","first-page":"dlaf031","DOI":"10.1093\/jacamr\/dlaf031","volume":"7","author":"Z Saleem","year":"2025","unstructured":"Saleem Z, Sheikh S, Godman B, Haseeb A, Afzal S, Qamar MU, et al. Increasing the use of the WHO AWaRe system in antibiotic surveillance and stewardship programmes in low- and middle-income countries. JAC Antimicrob Resist. 2025;7(2):dlaf031.","journal-title":"JAC Antimicrob Resist"},{"key":"13254_CR34","doi-asserted-by":"crossref","unstructured":"Gandra S, Kotwani A. Need to improve availability of access group antibiotics and reduce the use of watch group antibiotics in India for optimum use of antibiotics to contain antimicrobial resistance. J Pharm Policy Pract. 2019 Jul 17;12:20.","DOI":"10.1186\/s40545-019-0182-1"},{"key":"13254_CR35","doi-asserted-by":"crossref","unstructured":"Asmare Z, Erkihun M, Abebe W, Tamrat E. Antimicrobial resistance and ESBL production in uropathogenic Escherichia coli: a systematic review and meta-analysis in Ethiopia. JAC Antimicrob Resist. 2024 Jun;6(3):dlae068.","DOI":"10.1093\/jacamr\/dlae068"},{"key":"13254_CR36","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s13756-017-0243-7","volume":"6","author":"S Deyno","year":"2017","unstructured":"Deyno S, Fekadu S, Astatkie A. Resistance of Staphylococcus aureus to antimicrobial agents in Ethiopia: a meta-analysis. Antimicrob Resist Infect Control. 2017;6:85.","journal-title":"Antimicrob Resist Infect Control"},{"key":"13254_CR37","doi-asserted-by":"crossref","unstructured":"Iskandar K, Hanna PA, Salameh P, Raad EB. Antibiotic consumption in non-teaching Lebanese hospitals: a cross-sectional study. J Infect Public Health. 2016 Sept 1;9(5):618\u201325.","DOI":"10.1016\/j.jiph.2015.12.013"},{"key":"13254_CR38","doi-asserted-by":"crossref","unstructured":"Amaha ND, Weldemariam DG, Berhe YH. Antibiotic consumption study in two hospitals in Asmara from 2014 to 2018 using WHO\u2019s defined daily dose (DDD) methodology. Karunasagar I, editor. PLoS ONE. 2020 Jul 2;15(7):e0233275.","DOI":"10.1371\/journal.pone.0233275"},{"issue":"1","key":"13254_CR39","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1186\/s13690-024-01391-5","volume":"82","author":"H Song","year":"2024","unstructured":"Song H, Liu X, Zou K, Li H, Fei H, Huang L, et al. Assessment of antibiotic consumption patterns in hospital and primary healthcare using WHO Access, Watch and Reserve classification (AWaRe) in Sichuan Western China: 2020. Arch Public Health. 2024;82(1):182.","journal-title":"Arch Public Health"},{"key":"13254_CR40","doi-asserted-by":"crossref","unstructured":"Tarrant C, Colman AM, Jenkins DR, Chattoe-Brown E, Perera N, Mehtar S, et al. Drivers of broad-spectrum antibiotic overuse across diverse hospital contexts\u2014a qualitative study of prescribers in the UK, Sri Lanka and South Africa. Antibiotics [Internet]. 2021 Jan 19 [cited 2025 Dec 21];10(1). Available from: https:\/\/www.mdpi.com\/. 2079-6382\/10\/1\/94.","DOI":"10.3390\/antibiotics10010094"},{"issue":"1","key":"13254_CR41","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/s13756-019-0620-5","volume":"8","author":"ND Amaha","year":"2019","unstructured":"Amaha ND, Weldemariam DG, Abdu N, Tesfamariam EH. Prescribing practices using WHO prescribing indicators and factors associated with antibiotic prescribing in six community pharmacies in Asmara, Eritrea: a cross-sectional study. Antimicrob Resist Infect Control. 2019;8(1):163.","journal-title":"Antimicrob Resist Infect Control"},{"issue":"4","key":"13254_CR42","doi-asserted-by":"publisher","first-page":"189","DOI":"10.3390\/antibiotics8040189","volume":"8","author":"F Malik","year":"2019","unstructured":"Malik F, Figueras A. Analysis of the Antimicrobial Market in Pakistan: Is It Really Necessary Such a Vast Offering of Watch. Antimicrobials? Antibiot. 2019;8(4):189.","journal-title":"Antimicrobials? Antibiot"},{"issue":"1","key":"13254_CR43","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1186\/s13756-021-00965-0","volume":"10","author":"DF Berhe","year":"2021","unstructured":"Berhe DF, Beyene GT, Seyoum B, Gebre M, Haile K, Tsegaye M, et al. Prevalence of antimicrobial resistance and its clinical implications in Ethiopia: a systematic review. Antimicrob Resist Infect Control. 2021;10(1):168.","journal-title":"Antimicrob Resist Infect Control"},{"key":"13254_CR44","doi-asserted-by":"crossref","unstructured":"Legese MH, Asrat D, Swedberg G, Hasan B, Mekasha A, Getahun T, et al. Sepsis: emerging pathogens and antimicrobial resistance in Ethiopian referral hospitals. Antimicrob Resist Infect Control. 2022 Jun 13;11(1):83.","DOI":"10.1186\/s13756-022-01122-x"},{"key":"13254_CR45","doi-asserted-by":"crossref","unstructured":"Gelaw LY, Bitew AA, Gashey EM, Ademe MN. Ceftriaxone resistance among patients at GAMBY teaching general hospital. Sci Rep. 2022 Jul;14(1):12000.","DOI":"10.1038\/s41598-022-16132-3"},{"issue":"1","key":"13254_CR46","doi-asserted-by":"publisher","first-page":"25035","DOI":"10.1038\/s41598-024-75728-z","volume":"14","author":"C Tafere","year":"2024","unstructured":"Tafere C, Endeshaw D, Demsie DG, Yismaw MB, Tefera BB, Yehualaw A, et al. Inappropriate ceftriaxone utilization and predictor factors in Ethiopia: a systematic review and meta-analysis. Sci Rep. 2024;14(1):25035.","journal-title":"Sci Rep"},{"key":"13254_CR47","doi-asserted-by":"crossref","unstructured":"Amin A. The detection of ESBL-producing Escherichia coli in various clinical sample using 3rd generation cephalosporin by different diffusion methods. Int J Curr Microbiol App Sci. 2024 Jun 10;13(6):59\u201368.","DOI":"10.20546\/ijcmas.2024.1306.006"},{"key":"13254_CR48","doi-asserted-by":"publisher","first-page":"100944","DOI":"10.1016\/j.cegh.2021.100944","volume":"13","author":"AP Thomas","year":"2022","unstructured":"Thomas AP, Kumar M, Johnson R, More SP, Panda BK. Evaluation of antibiotic consumption and compliance to hospital antibiotic policy in the surgery, orthopedics and gynecology wards of a tertiary care hospital. Clin Epidemiol Global Health. 2022;13:100944.","journal-title":"Clin Epidemiol Global Health"},{"issue":"2","key":"13254_CR49","doi-asserted-by":"publisher","first-page":"e2253806","DOI":"10.1001\/jamanetworkopen.2022.53806","volume":"6","author":"K Zay Ya","year":"2023","unstructured":"Zay Ya K, Win PTN, Bielicki J, Lambiris M, Fink G. Association Between Antimicrobial Stewardship Programs and Antibiotic Use Globally: A Systematic Review and Meta-Analysis. JAMA Netw Open. 2023;6(2):e2253806.","journal-title":"JAMA Netw Open"},{"issue":"1","key":"13254_CR50","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s13756-025-01541-6","volume":"14","author":"I Pauwels","year":"2025","unstructured":"Pauwels I, Versporten A, Ashiru-Oredope D, Costa SF, Maldonado H, Porto APM, et al. Implementation of hospital antimicrobial stewardship programmes in low- and middle-income countries: a qualitative study from a multi-professional perspective in the Global-PPS network. Antimicrob Resist Infect Control. 2025;14(1):26.","journal-title":"Antimicrob Resist Infect Control"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-13254-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13254-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13254-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T21:28:44Z","timestamp":1781645324000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-026-13254-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,4]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["13254"],"URL":"https:\/\/doi.org\/10.1186\/s12879-026-13254-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7735816\/v1","asserted-by":"object"}]},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,4]]},"assertion":[{"value":"28 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval (Ref. No. MU-IRB 2210\/2024) was obtained from the Institutional Review Board of Mekelle University, College of Health Sciences, with additional support from the School of Pharmacy. The study was conducted in accordance with the Declaration of Helsinki. As the research involved a review of medical records without the collection of personal identifiers, the Institutional Review Board of Mekelle University waived the requirement for informed consent. Patient confidentiality was strictly maintained by excluding personal identifiers and recording only sociodemographic and prescription-related data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"962"}}